MBOT (Microbot Medical Inc) Market Value to Book Value Ratio

Microbot Medical Inc (MBOT) - corporate logo

The price history on the Microbot Medical Inc. (MBOT) chart demonstrates the dynamics of a company creating the unique, patent-protected Liberty disposable endovascular tool. The business relies on significant pricing power within the precision surgery segment, where demand is inelastic. Profitability is based on the sale of disposable components, which ensures scalability and margins at the level of 0.91, preventing the rapid emergence of market analogs.

MBOT - Microbot Medical, Inc Market-to-Book Ratio over the range 07/04/2022 - 10/27/2026
Manufactured products of Microbot Medical, Inc.

For the innovative startup Microbot Medical Inc. (MBOT), which develops unique disposable robots, a high market premium reflects investor expectations regarding a lack of competition and technological leadership. When analyzing the chart of the market cap to book value ratio, one must evaluate the gap between market value and net assets to determine the critical overvaluation threshold for the company before a potential cycle correction.

Direct competitors

ISRG - Market Cap to Net Assets Ratio|DHR (danaher.com) - Market Cap to Book Value Multiple|Market Value to Book Value Ratio BDX|Market Cap to Net Assets Ratio STERIS PLC|West Pharmaceutical Services Inc - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Baxter Healthcare (BAX)|MASI - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio stevanatogroup.com STVN|Market Capitalization to Book Value Ratio TFX (Teleflex)|MMSI - Market Capitalization to Book Value|NVST (Envista Holdings Corp) - Market Capitalization to Book Value Ratio|ICU Medical Inc. (ICUI) - Market Cap to Net Assets Ratio|XRAY (DENTSPLY SIRONA Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio LMAT|Market Value to Book Value Ratio AtriCure (ATRC)|Market Value to Book Value Ratio STAAR Surgical Co. STAA|Market Cap to Net Assets Ratio niagenbioscience.com|Market Value to Book Value ZimVie Corp ZIMV|Market Capitalization to Book Value Ratio ANGO (AngioDynamics, Inc.)|CERS: Market Capitalization to Book Value|Market Value to Book Value Ratio Teknova|MGRM (Monogram Technologies Inc.) - Capitalization to Book Value Ratio|STSS: Market Value to Book Value Ratio|Market Capitalization to Book Value InfuSystem Inc (INFU)|Market Cap to Net Assets Ratio Utah Medical Products|Market Cap to Book Value Multiple KRMD (korumedical.com)|Market Value to Book Value Ratio Nyxoah|PDEX - Market Value to Book Value|Zentek Limited - Market Cap to Net Assets Ratio|ELUT: Market Capitalization to Book Value Ratio|MLSS (Milestone Scientific) - Market Value to Book Value Ratio|nexgel.com (NXGL) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio RVP (Retractable Technologies Inc.)|Market-to-Book Ratio HBIO|Market Value to Book Value Ratio Femasys Corp FEMY|Capitalization to Book Value Ratio meihuamed.com MHUA|Market Cap to Net Assets Ratio Predictive Oncology Inc. (POAI)|Callan JMB Inc. - Market Cap to Book Value Multiple|Market Value to Book Value Ratio ATRI (Atrion)|NURO: Market Capitalization to Book Value